0

Endocrine Cancer Collection
 1-20 of 158 Articles
Original Research |  3 September 2013
A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation
Edmund S. Cibas, MD; Zubair W. Baloch, MD, PhD; Giovanni Fellegara, MD; et al.
Ann Intern Med. 2013;159(5):325-332. doi:10.7326/0003-4819-159-5-201309030-00006
Editorials |  1 September 2009
Primary Aldosteronism—One Picture Is Not Worth a Thousand Words
William F. Young, MD, MSc
Ann Intern Med. 2009;151(5):357-358. doi:10.7326/0003-4819-151-5-200909010-00013
Reviews |  1 September 2009
Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism
Marlies J.E. Kempers, MD, PhD; Jacques W.M. Lenders, MD, PhD; Lieke van Outheusden, MSc; et al.
Ann Intern Med. 2009;151(5):329-337. doi:10.7326/0003-4819-151-5-200909010-00007
Articles |  6 January 2009 FREE
Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma
Smita K. Baid, MD; Edwin W. Lai, BS; Robert A. Wesley, PhD; et al.
Ann Intern Med. 2009;150(1):27-32. doi:10.7326/0003-4819-150-1-200901060-00006
Reviews |  7 June 2005
Continuing Controversies in the Management of Thyroid Nodules
M. Regina Castro, MD; Hossein Gharib, MD
Ann Intern Med. 2005;142(11):926-931. doi:10.7326/0003-4819-142-11-200506070-00011
Brief Communications |  18 February 2003
Natural History of Benign Solid and Cystic Thyroid Nodules
Erik K. Alexander, MD; Shelley Hurwitz, PhD; Jenny P. Heering, BA; et al.
Ann Intern Med. 2003;138(4):315-318. doi:10.7326/0003-4819-138-4-200302180-00010
Brief Communications |  21 August 2001
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
Anna M. Sawka, MD; William F. Young, MD; Geoffrey B. Thompson, MD; et al.
Ann Intern Med. 2001;135(4):258-261. doi:10.7326/0003-4819-135-4-200108210-00010
Articles |  15 October 1998
Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
Terry Taylor, MD; Bonny Specker, PhD; Jacob Robbins, MD; et al.
Ann Intern Med. 1998;129(8):622-627. doi:10.7326/0003-4819-129-8-199810150-00007
Editorials |  1 March 1998
Medical Treatment of Benign Thyroid Nodules: Have We Defined a Benefit?
E. Chester Ridgway, MD
Ann Intern Med. 1998;128(5):403-405. doi:10.7326/0003-4819-128-5-199803010-00010
Editorials |  15 August 1996
Plasma or Urinary Metanephrines for the Diagnosis of Pheochromocytoma? That Is the Question
Emmanuel L. Bravo, MD
Ann Intern Med. 1996;125(4):331-332. doi:10.7326/0003-4819-125-4-199608150-00012
Brief Communications |  15 August 1996
The Urinary Metanephrine-to-Creatinine Ratio for the Diagnosis of Pheochromocytoma
Emmanuel Heron, MD; Gilles Chatellier, MD; Eliane Billaud, PhD; et al.
Ann Intern Med. 1996;125(4):300-303. doi:10.7326/0003-4819-125-4-199608150-00008
Articles |  1 July 1996
Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study
Fathia Gibril, MD; James C. Reynolds, MD; John L. Doppman, MD; et al.
Ann Intern Med. 1996;125(1):26-34. doi:10.7326/0003-4819-125-1-199607010-00005
Editorials |  15 July 1995
Searching for Pheochromocytoma: A New and Better Test?
Lawrence R. Krakoff, MD
Ann Intern Med. 1995;123(2):150-151. doi:10.7326/0003-4819-123-2-199507150-00011
Articles |  15 July 1995
Plasma Metanephrines in the Diagnosis of Pheochromocytoma
Jacques W. M. Lenders; Harry R. Keiser; David S. Goldstein; et al.
Ann Intern Med. 1995;123(2):101-109. doi:10.7326/0003-4819-123-2-199507150-00004
Diagnosis and Treatment |  15 January 1995
Genetic Testing in the Diagnosis and Management of Multiple Endocrine Neoplasia Type II
Gregory A. Ledger, MD; Sundeep Khosla, MD; Noralane M. Lindor, MD; et al.
Ann Intern Med. 1995;122(2):118-124. doi:10.7326/0003-4819-122-2-199501150-00008
Editorials |  1 January 1995
Why Do Clinicians Continue to Debate the Use of Levothyroxine in the Diagnosis and Management of Thyroid Nodules?
Manfred Blum, MD
Ann Intern Med. 1995;122(1):63-64. doi:10.7326/0003-4819-122-1-199501010-00011
Reviews |  1 December 1994
Diagnosis and Treatment of Primary Hyperaldosteronism
Jon D. Blumenfeld, MD; Jean E. Sealey, ScD; Yvette Schlussel, PhD; et al.
Ann Intern Med. 1994;121(11):877-885. doi:10.7326/0003-4819-121-11-199412010-00010
Editorials |  1 August 1994
Omeprazole, Hypergastrinemia, and Gastric Carcinoid Tumors
James W. Freston, MD, PhD
Ann Intern Med. 1994;121(3):232-233. doi:10.7326/0003-4819-121-3-199408010-00012
Brief Reports |  15 March 1994
Silent Adrenal Nodules in von Hippel-Lindau Disease Suggest Pheochromocytoma
Brian S. Aprill, MD; Almond J. Drake, MD; David H. Lasseter, MD; et al.
Ann Intern Med. 1994;120(6):485-487. doi:10.7326/0003-4819-120-6-199403150-00006
Articles |  1 August 1993
Assessment and Prediction of Long-term Cure in Patients with the Zollinger-Ellison Syndrome: The Best Approach
Vitaly A. Fishbeyn, MD; Jeffrey A. Norton, MD; Richard V. Benya, MD; et al.
Ann Intern Med. 1993;119(3):199-206. doi:10.7326/0003-4819-119-3-199308010-00004
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)